About ReversingLabs
ReversingLabs is a private company based in Cambridge, Massachusetts. It has reported $120,149,406 raised in three offerings on Form D since December 2017. Its chief executive is Mario Vuksan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 25, 2024 | May 15, 2024 | $38,649,446of $62.7M target | 3 | $12.8M | EquityRule 506(b) | Form D ↗ |
| Jul 30, 2021 | Aug 3, 2021 | $56,499,960of $66.4M target | 7 | $8.0M | EquityRule 506(b) | Form D ↗ |
| Nov 7, 2017 | Dec 1, 2017 | $25,000,000fully sold | 3 | $8.3M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $120,149,406 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ReversingLabs's Form D filed May 15, 2024.
MV
Mario Vuksan
Chief Executive Officer and director
TP
Tomislav Pericin
Director
HT
Hugh Thompson
Director
DL
Douglas Levin
Director
AY
Alberto Yepez
Director
GC
Earlier filings also listed W. Patrick Opet (director, last listed Aug 2021) and Sean Cunningham (director, last listed Aug 2021).